⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
Kaplan Fox Reminds Investors of ARS Pharmaceuticals Inc. (SPRY) to a Securities Class Action Deadline - Contact the Firm Before October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Recover Losses - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
SPRY
Securities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Notifies Investors of Class Action Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
October 5, 2026 Deadline Approaching: Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky
accessnewswire.com
SPRY
Join Class Action to Recover Losses From ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky Before October 5, 2026
accessnewswire.com
SPRY
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY
globenewswire.com
SPRY
SPRY LAWSUIT ALERT: Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. Investors - Lead Plaintiff Deadline October 5, 2026
accessnewswire.com
SPRY